Browsing Tag
Argent Biopharma Limited
2 posts
Argent Biopharma (ASX: RGT) shares rise 7.69% as U.S. in vivo study validates ArtemiC efficacy in Alzheimer’s model
Argent Biopharma gains 7.69% after U.S. in vivo Alzheimer’s study validates ArtemiC’s plaque-reducing effects. Read more on RGT’s strategy and market outlook.
Argent Biopharma and Galan Lithium soar as ASX defies Trump tariffs with surprise stock rally
Despite Trump’s tariff shock hitting the ASX, several small-cap stocks soared on April 3. Discover which companies defied the selloff and why investors took notice.